Overall rank by patents
#41,027
Across all tracked assignees
USPTO PatentsView assignee record - 6 granted patents across 2 technology areas, active 2020–2024. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61M (DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY ; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY ; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR).
The verdict
Invent holds 6 US patents across 2 technology areas, rank #41,027 of 50,000 tracked assignees.
Invent Medical Corporation has been granted 6 US utility patents between 2020 and 2024, placing Invent Medical Corporation at rank #41,027 across all assignees tracked by PlainPatent. This portfolio spans 2 distinct Cooperative Patent Classification (CPC) subclasses, averaging 22.2 claims per patent with primary concentration in A61M (DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY ; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY ; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR). As a US Corporation, Invent Medical Corporation is one of the more focused assignees in the PatentsView dataset. By volume, Invent sits between Intocell, Inc. (6 patents, rank #41,023) and Invisible Hand Enterprises, Llc (6 patents, rank #41,031) - the closest US assignees by grant volume. The composite Innovation Score of 38.4/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Historical data spans 2020 through 2024, with 6 total grants over that period. Velocity comparisons require five years of historical filings to calibrate. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Invent Medical Corporation's 22.2 average claims per patent reflects complex, broadly scoped inventions that are difficult for competitors to design around, while specialization in 2 subclasses reflects a tightly scoped invention area. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Invent Medical Corporation against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
IntoCell, Inc.
6 patents
IntraOp Medical Corporation
6 patents
Intraco, Inc.
6 patents
Intrinsic Medical Imaging, LLC
6 patents
InventChip Technology Co., Ltd.
6 patents
Inventive Solutions LLC
6 patents
Invirsa, Inc.
6 patents
Invisible Hand Enterprises, LLC
6 patents
Invent Medical Corporation
6 patents
What this shows Invent holds 6 patents at rank #41,027, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #41,027 in granted patent volume.
Other assignees with the most granted patents in Invent's primary technology class.
Invent's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
38 Top 41% higher than 59% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2020–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2020 | 2 | 33.3% |
| 2022 | 2 | 33.3% |
| 2023 | 1 | 16.7% |
| 2024 | 1 | 16.7% |
Top 2 of 2 technology areas
Overall rank by patents
#41,027
Across all tracked assignees
38.4 out of 100
How to use this portfolio
Invent's 6 grants land it in the top 41% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.